首页 > 妇产科临床医学（英文） > Guidelines for the clinical application of prophylactic human papillomavirus(HPV)vaccines in China(2025 edition)

Guidelines for the clinical application of prophylactic human papillomavirus(HPV)vaccines in China(2025 edition)

导出在线阅读解读下载全文终端阅读

二维码有效期 120s

点击刷新

注：终端设备浏览有效期：

学术成果认领

翻译打印收藏纠错

摘要Prophylactic human papillomavirus(HPV)vaccination is a primary preventive measure aimed at preventing HPV-related lesions and cancers by preventing HPV infection.With the continuous update of global data on HPV vaccination,seven academic societies-including the Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association and Chinese Society of Gynecological oncology,Chinese Medical Association and others-have jointly devel-oped the Guidelines for the Clinical Applica-tion of Prophylactic Human Papillomavirus(HPV)Vaccines in China(2025 Edition).This guideline was based on the previous Chinese Expert Consensus on the Clinical Application of Human Papillomavirus Vaccines1 as well as current evidence-based medical research,China's national conditions and clinical real-ities.The recommended categories of this guideline are listed in table 1.

作者 Mingzhu Li ^[1] Fanghui Zhao ^[2] Rutie Yin ^[3] Xinyu Wang ^[4] Qing Cong ^[5] Shuang Li ^[6] Long Sui ^[5] Beihua Kong ^[7] Ding Ma ^[8] Lihui Wei ^[1] 学术成果认领

作者单位 Department of Obstetrics and Gynecology,Peking University People's Hospital,Beijing,China;Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association(CSCCP),Beijing,China ^[1] Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association(CSCCP),Beijing,China;Department of Cancer Epidemiology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China;Branch of Cancer Prevention and Control,Chinese Preventive Medicine Association,Beijing,China ^[2] Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association(CSCCP),Beijing,China;Department of Obstetrics and Gynecology,West China Second Hospital of Sichuan University,Chengdu,China ^[3] Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association(CSCCP),Beijing,China;Department of Obstetrics and Gynecology,The First Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,China ^[4] Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association(CSCCP),Beijing,China;Diagnosis and Treatment Center of Cervical Disease,Obstetrics & Gynecology Hospital of Fudan University,Shanghai,China ^[5] Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association(CSCCP),Beijing,China;Department of Obstetrics and Gynecology,Tongji Medical College of HUST,Wuhan,China ^[6] Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association(CSCCP),Beijing,China;Department of Obstetrics and Gynecology,Qilu Hospital of Shandong University,Jinan,China;Chinese Society of Gynecological oncology,Chinese Medical Association,Jinan,China ^[7] Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association(CSCCP),Beijing,China;Department of Obstetrics and Gynecology,Tongji Medical College of HUST,Wuhan,China;Chinese Society of Gynecological oncology,Chinese Medical Association,Jinan,China ^[8]

栏目名称

Guideline

DOI 10.1136/gocm-2025-000285

发布时间 2025-10-29（万方平台首次上网日期，不代表论文的发表时间）

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交